Chantale FARAH - Thesis defence

Chantale FARAH - Biomedical Magnetic Resonance Group (REMA)/LDRI

Assessment of early metabolic markers of response to targeted and immune therapies using 13C Magnetic Resonance Spectroscopy in melanoma xenografts

Promotor: Prof. Bénédicte Jordan

Co-promotor: Prof. Jean François Baurain

Related references:

• Farah C, Neveu MA, Yelek C, Bouzin C, Gallez B, Baurain JF, Mignion L, Jordan BF. Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts Biomedicines. 2022;10(3):717
• Farah C, Neveu MA, Bouzin C, Knezevic Z, Gallez B, Leucci E, Baurain JF, Mignion L, Jordan BF. Hyperpolarized 13C-Pyruvate to Assess Response to Anti-PD1 Immune Checkpoint Inhibition in YUMMER 1.7 Melanoma Xenografts. Int J Mol Sci. 2023 ;24(3):2499.

This thesis defence took place on September 26, 2023.